Printer Friendly Version
Printer Friendly Version
S.5.01.625
Apretude (cabotegravir extended-release injectable suspension)
Please perform a search of the State Health Plan Medical Drug Formulary for drugs administered and billed through the medical setting.
Apretude (cabotegravir extended-release injectable suspension) is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition.
Apretude (cabotegravir extended-release injectable suspension) is considered not medically necessary for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 as there are other alternatives covered by the Plan.
Services related to delivery and/or administration of a medication determined to be not medically necessary will also be considered not medically necessary.
None
Medical Policy Manual coverage guidelines should not be used in lieu of the Participant's specific benefit plan language outlined in the Mississippi's State and School Employees’ Life and Health Insurance Plan.
Medically Necessary is defined as those services, treatments, procedures, equipment, drugs, devices, items or supplies furnished by a covered Provider that are required to identify or treat a Participant’s illness, injury or Mental Health Disorders, and which Company determines are covered under this Benefit Plan based on the criteria as follows in A through D:
A. consistent with the symptoms or diagnosis and treatment of the Participant’s condition, illness, or injury; and
B. appropriate with regard to standards of good medical practice; and
C. not solely for the convenience of the Participant, his or her Provider; and
D. the most appropriate supply or level of care which can safely be provided to the Participant. When applied to the care of an Inpatient, it further means that services for the Participant’s medical symptoms or conditions require that the services cannot be safely provided to the Participant as an Outpatient.
For the definition of medical necessity, “standards of good medical practice” means standards that are based on credible scientific evidence published in peer-reviewed medical literature generally recognized by the relevant medical community, and physician specialty society recommendations, and the views of medical practitioners practicing in relevant clinical areas and any other relevant factors. BCBSMS makes no payment for services, treatments, procedures, equipment, drugs, devices, items or supplies which are not documented to be Medically Necessary. The fact that a Physician or other Provider has prescribed, ordered, recommended, or approved a service or supply does not in itself, make it Medically Necessary.
BCBSMS may request medical records for determination of medical necessity. When medical records are requested, letters of support and/or explanation are often useful, but are not sufficient documentation unless all specific information needed to make a medical necessity determination is included.
09/15/2025: New policy added.
Apretude prescribing information. ViiV Healthcare Company. April 2025. Last accessed September 2025.
This may not be a comprehensive list of procedure codes applicable to this policy.
Not Medically Necessary Codes
Code Number | Description |
CPT-4 | |
HCPCS | |
J0739 | Injection, cabotegravir, 1 mg, FDA-approved prescription, only for use as HIV pre-exposure prophylaxis (not for use as treatment for HIV) |
ICD-10 Procedure | |
ICD-10 Diagnosis |
CPT copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.